T1	Drug-Class 218 226	platinum
T11	Drug 732 741	cisplatin
T12	Disease 732 755	cisplatin-resistant EOC
T14	Drug-Class 877 885	platinum
T15	Disease 907 910	EOC
T17	Drug-Class 1078 1086	platinum
T18	Disease 1101 1104	EOC
T20	Drug-Class 1200 1208	platinum
T21	Drug-Class 1496 1504	platinum
T3	Drug-Class 347 355	platinum
T5	Chemical 436 439	CpG
T8	Drug-Class 599 607	platinum
T9	Disease 622 625	EOC
T2	Gene-Protein 109 114	hMSH2
#1	AnnotatorNotes T2	HGNC:7325
T4	Gene-Protein 139 144	Mef-2
#2	AnnotatorNotes T4	HGNC:17940
T6	Gene-Protein 146 150	HNFα
#3	AnnotatorNotes T6	HGNC:11621
T7	Gene-Protein 156 158	GR
#4	AnnotatorNotes T7	HGNC:7978
T13	Biomarker 267 329	hMSH2 mRNA and protein levels were significantly downregulated
T16	Gene-Protein 267 272	hMSH2
T19	Gene-Protein 465 470	hMSH2
T22	Biomarker 518 585	loss of expression due to hypermethylation of hMSH2 upstream region
T23	Gene-Protein 564 569	hMSH2
R1	Non-Response Arg1:T8 Arg2:T9	
#5	AnnotatorNotes T9	DOID:2152
T24	Biomarker 662 715	hypermethylation of another essential MMR gene, hMLH1
T25	Gene-Protein 710 715	hMLH1
#6	AnnotatorNotes T25	HGNC:7127
#7	AnnotatorNotes T11	CHEMBL11359
#8	AnnotatorNotes T12	not found
R3	Association Arg1:T24 Arg2:T12	
T27	Gene-Protein 847 852	hMSH2
T28	Biomarker 997 1042	hypermethylation of the hMSH2 upstream region
T29	Gene-Protein 1021 1026	hMSH2
R4	Non-Response Arg1:T17 Arg2:T18	
T30	Biomarker 1139 1174	increase of hMLH1 methylation level
T31	Gene-Protein 1151 1156	hMLH1
T32	Biomarker 1474 1491	hMLH1 methylation
T33	Gene-Protein 1474 1479	hMLH1
T34	Biomarker 408 444	methylation level of − 1164 CpG site
T35	Biomarker 465 486	hMSH2 mRNA expression
T36	Gene-Protein 800 805	hMSH2
T26	Biomarker 792 861	loss of hMSH2 expression caused by hypermethylation of hMSH2 promoter
T37	Gene-Protein 1709 1714	hMLH1
T10	Biomarker 83 171	− 1164 upstream region of hMSH2, a transcription factor Mef-2, HNFα, and GR binding site
